Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters
Database
Main subject
Language
Document Type
Year range
1.
Ad26.COV2.S or BNT162b2 Boosting of BNT162b2 Vaccinated Individuals (preprint)
C. Sabrina Tan; Ai-ris Collier; Jinyan Liu; Jingyou Yu; Huahua Wan; Katherine McMahan; Xuan He; Catherine Jacob-Dolan; Abishek Chandrashekar; Daniel Sellers; Kathryn Stephenson; Samuel Vidal; Kate Jaegle; Jessica Curran; Marjorie Rowe; Rachel Hemod; Lorriane Bermudez Rivera; Tochi Anioke; Julia Barrett; Benjamin Chung; Sarah Gardner; Makda Gebre; Michelle Lifton; Olivia Powers; Haley VanWyk; Cindy Wu; Dan Barouch.
medrxiv; 2021.
Preprint in English | medRxiv | ID: ppzbmed-10.1101.2021.12.02.21267198

ABSTRACT

Previous studies have reported that a third dose of the BNT162b2 (Pfizer) COVID-19 vaccine increased antibody titers and protective efficacy. Here we compare humoral and cellular immune responses in 65 individuals who were vaccinated with the BNT162b2 vaccine and were boosted after at least 6 months with either Ad26.COV2.S (Johnson & Johnson; N=41) or BNT162b2 (Pfizer; N=24).


Subject(s)
COVID-19
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL